Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$46.1B
120M shares
52-week range
$163.11 – $397.99
99% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
CS
Borrow rate
0.40%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $56.94B | $64.93B | $77.19B | $83.65B | $92.92B | $106.44B | $117.81B | $129.66B |
| Cost of revenue | $45.75B | $53.74B | $61.50B | $69.20B | $75.69B | $88.39B | $100.66B | $110.81B |
| Gross profit | $11.19B | $11.19B | $15.69B | $14.45B | $17.23B | $18.05B | $17.15B | $18.85B |
| Gross margin | 19.7% | 17.2% | 20.3% | 17.3% | 18.5% | 17.0% | 14.6% | 14.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $2.07B | $3.47B | $4.67B | $3.42B | $3.56B | $3.32B | $1.63B | $1.45B |
| EBITDA | $2.83B | $4.29B | $5.57B | $4.46B | $4.81B | $4.73B | $3.25B | $2.91B |
| Net income | $1.68B | $2.71B | $3.37B | $2.93B | $2.81B | $2.49B | $1.21B | $1.19B |
| Net margin | 3.0% | 4.2% | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| EPS (diluted) | 12.16 | 20.10 | 25.31 | 22.67 | 22.08 | 20.00 | 9.98 | 9.84 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $162.1B | $8.85 | $8.27–$9.17 | 15 |
| 2027 | $169.7B | $15.84 | $13.51–$19.05 | 15 |
| 2028 | $179.4B | $26.34 | $20.04–$32.21 | 7 |
| 2029 | $188.2B | $32.39 | $31.02–$34.70 | 2 |
Forward consensus · source: Financial Modeling Prep
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
www.humana.comNo one on the platform currently holds HUM.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 9,953 | $2.5M |
| Bridgewater Associatesas of 2025-09-30 | 6,603 | $1.7M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-26 | $0.8850 | 2026-07-31 |
| 2026-03-27 | $0.8850 | 2026-04-24 |
| 2025-12-26 | $0.8850 | 2026-01-30 |
| 2025-09-26 | $0.8850 | 2025-10-31 |
| 2025-06-27 | $0.8850 | 2025-07-25 |
| 2025-03-28 | $0.8850 | 2025-04-25 |
| 2024-12-31 | $0.8850 | 2025-01-31 |
| 2024-09-30 | $0.8850 | 2024-10-25 |
| 2024-06-28 | $0.8850 | 2024-07-26 |
| 2024-03-27 | $0.8850 | 2024-04-26 |
No one on the platform has traded HUM yet.
| $28.9B |
| — |
| HLNHaleon plc | $9.34 | +0.05% | $41.2B | — |
| INSMInsmed Incorporated | $107.20 | +2.35% | $23.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-28 |
| $0.8850 |
| 2024-01-26 |
| 2023-09-28 | $0.8850 | 2023-10-27 |
Trading at 27.9× earnings vs its 24.5× historical median P/E.
Fair value ≈ $346.73 · price $395.49 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$HUM lol if yiur not buying hum stock your losing out and if your betting against it your sure to lose. Coming from an insider I can say you are playing with fire. They have a deal with Mark Cuban. We have new drugs we rolled out that are making bank. Top dollar. Not only that we have some partnerships brewing. Definitely going to see that at $1000 🤑🤑🤑🤑
View on StockTwits ↗$HUM this is a wierd one in comparison to peers. Especially considering they cant afford to pay commissions to their agents rn. Kinda think we see sub 300 on earnings.
View on StockTwits ↗$HUM Damn ......this one hurt bulls, but congratulations to all the ones that held through hell a few months ago. Talk about timing....it looks like I took my mental break from the markets at the wrong time, lol Altho I walked away break-even or with a slight profit....it looks like I left 185k on the table!!!!! 🤬
View on StockTwits ↗$HUM this stock will be at $1000 a share soon .. Mark my words. Use to be at 600 . Easy money 💰
View on StockTwits ↗$CLOV According to Grok, there is a deal in the works with Humana $HUM
View on StockTwits ↗$HUM Current Stock Price: $383.57 Contracts to trade: $382.5 HUM Jun 26 2026 Call Entry: $0.10 Exit: $0.19 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$CLOV $HUM just hit a 52 wk high, following $UNH and $CLOV
View on StockTwits ↗@jacksparo we are waiting for $HUM for shorts to pay their price as well
View on StockTwits ↗$CI $CNC $CVS $HUM $UNH Healthcare stocks own 2026 besides the crazy chip stocks.
View on StockTwits ↗$ASTH here’s math. 350mm 27 ebitda 14x ($INNV trades for this valuation; max health acquired by $HUM a few months ago for this valuation) 4.9bn -500mm net debt $4.4bn /55mm shares $80/sh target price This isn’t a stretch and this isn’t a meme stock. This is a real cash flowing biz with years of 15-20% growth runway.
View on StockTwits ↗@cynicaloptimist @BustaCapital @Jblack500 @MaverikIT @IsabellaDC @WAJeff $MOH $UNH $HUM $OSCR $CNC alerting again to managed care stock sector. Day 1 of MOH breakout. This breakout took more than 4 attempts and some time to develop which makes me respect the move more. Led the way in the sector today in terms of vol vs avg. Now just give me a little backtest to make one more buy.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.